Rationale for interleukin-6 blockade in systemic lupus erythematosus

Lupus
E TackeyG G Illei

Abstract

Interleukin-6 (IL-6) is a pleiotropic cytokine with a wide range of biological activities that plays an important role in immune regulation and inflammation. Among other actions, it induces terminal differentiation of B lymphocytes into antibody-forming cells and the differentiation of T cells into effector cells. IL-6 also has multiple potent proinflammatory effects. An association between IL-6 and lupus was demonstrated in murine models of SLE and blocking IL-6 improved lupus in all models tested. Data from several studies suggest that IL-6 plays a critical role in the B cell hyperactivity and immunopathology of human SLE, and may have a direct role in mediating tissue damage. Based on these data, we propose that blocking the effect of IL-6 in humans may improve lupus by interacting with the autoinflammatory process both systemically and locally.

References

Mar 1, 1992·Clinical Immunology and Immunopathology·M E Alarcón-RiquelmeC Fernández
Mar 1, 1991·International Immunology·B TangT Kishimoto
Jan 1, 1994·Virchows Archiv : an International Journal of Pathology·T TakemuraS Maki
Aug 1, 1994·The Journal of Clinical Investigation·B K FinckD Wofsy
Feb 1, 1993·Clinical and Experimental Immunology·M E Alarcón-RiquelmeC Fernández
Jun 2, 1998·Lupus·R Herrera-EsparzaE Avalos-Díaz
Jul 2, 1998·Clinical and Experimental Immunology·M MiharaY Ohsugi
Jul 8, 1998·Proceedings of the National Academy of Sciences of the United States of America·S OhshimaT Kishimoto
Apr 29, 1999·Clinical Immunology : the Official Journal of the Clinical Immunology Society·M Linker-IsraeliJ R Klinenberg
Mar 10, 2001·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·C L YuH S Yu
May 9, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·G FilaciF Indiveri
Jul 12, 2002·Arthritis Research·Tetsuji NakaTadamitsu Kishimoto
Jan 18, 2003·Science·Chandrashekhar Pasare, Ruslan Medzhitov

❮ Previous
Next ❯

Citations

Oct 19, 2006·Springer Seminars in Immunopathology·Adeeb H Rahman, Robert A Eisenberg
May 21, 2008·Zeitschrift für Rheumatologie·M AringerJ Smolen
Jun 22, 2010·Clinical Rheumatology·Jilin MaSong Guo Zheng
Nov 8, 2006·Inflammation·Shannon D McClintockKent J Johnson
Jun 29, 2011·Journal of Clinical Immunology·Brahim SelmaouiYvan Touitou
Jan 22, 2008·Expert Reviews in Molecular Medicine·Meera Ramanujam, Anne Davidson
Aug 26, 2006·Nature Clinical Practice. Rheumatology·Robert Eisenberg, Daniel Albert
Jul 4, 2006·Nature Reviews. Drug Discovery·Jeffrey L Browning
Oct 29, 2010·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Jalal A JazayeriGraeme J Carroll
Jun 27, 2006·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Marcello MaggioLuigi Ferrucci
Feb 3, 2011·Rheumatology·Katrine B NorheimRoald Omdal
Nov 14, 2007·International Journal of Clinical Practice·J Ermann, B L Bermas
Oct 27, 2011·Journal of Biomedicine & Biotechnology·Kim Ohl, Klaus Tenbrock
Dec 13, 2012·International Journal of Nanomedicine·Yang PanLunan Wang
Dec 14, 2011·Immunotherapy·Toshio Tanaka, Tadamitsu Kishimoto
Nov 19, 2013·Cellular & Molecular Immunology·Cristen B ChafinChristopher M Reilly
Sep 25, 2010·Joint, Bone, Spine : Revue Du Rhumatisme·Christophe RichezThierry Schaeverbeke
May 15, 2010·Journal of Biomedicine & Biotechnology·Desmond Yat Hin Yap, Kar Neng Lai
Jan 30, 2014·International Reviews of Immunology·Tiffany CazaAndras Perl
Mar 28, 2008·Expert Review of Molecular Diagnostics·Chang-Hee Suh, Hyoun-Ah Kim
Sep 6, 2014·Expert Opinion on Investigational Drugs·Uma Thanarajasingam, Timothy B Niewold
Jul 11, 2008·Expert Opinion on Drug Safety·Martin Aringer, Josef S Smolen
Jan 15, 2014·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Brad H Rovin, Samir V Parikh
Feb 2, 2015·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Mohammed M Al GadbanSamar M Hammad
Nov 5, 2013·Rheumatic Diseases Clinics of North America·Michael Bennett, Hermine I Brunner
Jul 6, 2013·Dermatologic Clinics·William Abramovits, Marcial Oquendo
Oct 31, 2012·Cytokine & Growth Factor Reviews·Parvin Ataie-KachoieDavid L Morris
Jun 26, 2012·Journal of Autoimmunity·Jennifer S MichaelsonChaim Putterman
Jul 4, 2008·Kidney International·Xiaolan ZhangBrad H Rovin
Oct 30, 2010·La Revue de médecine interne·L Arnaud, Z Amoura
Jul 14, 2009·Best Practice & Research. Clinical Rheumatology·Elsa Sousa, David Isenberg
Jul 16, 2008·La Revue de médecine interne·Z AmouraJ-C Piette
Nov 24, 2007·Autoimmunity Reviews·Andrea Picchianti DiamantiGuido Valesini
Jan 16, 2007·Experimental and Molecular Pathology·Shannon D McClintockKent J Johnson
Feb 26, 2016·Expert Review of Clinical Pharmacology·Huza ZhangMaria J Cuadrado
Nov 28, 2008·Arthritis and Rheumatism·Shilpa GaitondeIrving Kushner
Feb 20, 2008·Oral Diseases·Y ShirotaN P Nikolov

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.